INS and Hyperglycemia: In addition, transplantation of mesenchymal stem cells that successfully differentiated into insulin-producing cells was able to correct streptozotocin-induced hyperglycemia in diabetic rodents and to improve survival of transplanted islets and has also been found to be beneficial for the treatment of noninsulin-dependent patients40.